PLYMOUTH MEETING, Pa., Aug. 9,?2021 /PRNewswire/ — Harmony Biosciences Holdings, Inc. (“Harmony”) (Nasdaq: HRMY), a pharmaceutical company dedicated to?developing and commercializing innovative ...
Acquisition represents the first step in Harmony's plan to build a robust portfolio of products to treat patients living with rare neurological diseases who have significant unmet medical needs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results